Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture: A Single-center Randomized, Controlled Trial.
General anesthesia
+ Spinal anesthesia
+ General anesthesia
Blessures de la jambe+1
+ Blessures et lésions
+ Fractures osseuses
Soins de support
Résumé
Date de début de l'étude : 1 mars 2012
Date à laquelle le premier participant a commencé l'étude.For some of the patients RA may be even more safe than GA. According to a large meta-analysis RA reduces the risk of several complications versus GA. Risk of deep vein thrombosis is reduced by 44% Risk of pulmonary embolism is reduced by 55 % Risk of major bleeding is reduced by 50% Risk of post operative pneumonia is reduced by 39% Risk of post operative respiratory is reduced by 59% It is generally thought that RA is safer than GA for example in patients with heart or pulmonary diseases. It is also known that the use of RA reduces postoperative need of opioids, which leads to improved respiratory function and reduced post operative disorientation, delirium and nausea. Purpose of the study: Our purpose is to gain more information of the safety of RA in patients with tibial fracture. Our hypothesis is that RA is equally safe with GA. Implementation: Research begins with a pilot study in which RA is compared with GA. There are about 65 tibial fractures operated in our centre every year. We randomize patients to GA group (n=25) and spinal anaesthesia group (n=25). We presume that RA is equally safe with GA. However, power analysis has been made presuming that RA will increase the risk of ACS. We calculated the sample size by assuming that the compartment pressure in RA group is 10 mmHg higher than in the GA group. GA will be inducted by fentanyl, propofol and rocuronium. GA will be maintained by sevofluran, fentanyl and rocuronium. Spinal-anaesthesia will be performed by using hyperbaric bupivacaine. The dose is 10-15 mg, depending on the needs of the patient. This will maintain RA in lower extremities for 2-4 hours, which is enough to operate a tibial shaft fracture. In both study groups the post-operative pain will be treated by intravenous and peroral oxycodone and paracetamol. Monitoring and ethics: Clinical examination every hour in recovery room (oedema, temperature, cutaneous sensation, distal pulses) Continuous pressure-measurement of anterior compartment in the operated leg for 24 hours Local oxygen metabolism measured by near-infrared spectroscopy in the operated leg for 24 hours Patients will be monitored in the recovery room for 24 hours after operation. Blood tests (creatine kinase and myoglobin) will be drawn before operation, when arriving in recovery room, 6 hours and 24 hours after operation in each patient.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.50 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Soins de support
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.À partir de 18 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
Inclusion Criteria: Patients with a unilateral tibial shaft fracture which needs to be operated are included. Exclusion Criteria: refusal of the patient severe, generalized atherosclerosis massive obesity marked mental retardation, dementia bilateral tibial shaft fracture polytrauma, such as head injury bleeding diathesis aortic stenosis infection at the injection site certain medications affecting bleeding sepsis hypovolemia conversion to general anaesthesia due to technical difficulties anesthesiologist has a strong opinion towards GA/RA foreign patient and marked translation difficulties
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.2 groupes d'intervention sont désignés dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
Comparateur actifGroupe II
Comparateur actifObjectifs de l'étude
Objectifs principaux
Objectifs secondaires
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 1 site